Changes in adiponectin level and fat distribution in patients with type 2 diabetes. (Q51331101)

3 April 2018

title

Changes in adiponectin level and fat distribution in patients with type 2 diabetes. (English)

1 reference

3 April 2018

1 reference

Krystyna Widecka

5

0 references

Tomasz Miazgowski

object named as

Tomasz Miazgowski

1

0 references

Krzysztof Safranow

object named as

Krzysztof Safranow

3

0 references

author name string

Joanna Dziwura-Ogonowska

2

1 reference

3 April 2018

Katarzyna Iskierska

4

1 reference

3 April 2018

publication date

9 December 2013

1 reference

3 April 2018

European Journal of Clinical Investigation

published in

1 reference

3 April 2018

volume

44

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

192-199

1 reference

3 April 2018

Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study

cites work

1 reference

Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome

21 January 2018

1 reference

Adipose tissue remodeling and obesity

21 January 2018

1 reference

Association between adiponectin and metabolic syndrome in older adults from major cities of China.

21 January 2018

1 reference

Mitochondrial dysfunction in obesity

21 January 2018

1 reference

Hypoadiponectinemia--cause or consequence of human "insulin resistance"?

21 January 2018

1 reference

Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?

21 January 2018

1 reference

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women

21 January 2018

1 reference

A catalogue of reporting guidelines for health research

21 January 2018

1 reference

Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.

21 January 2018

1 reference

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

21 January 2018

1 reference

The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults

21 January 2018

1 reference

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus

21 January 2018

1 reference

Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects

21 January 2018

1 reference

Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes

21 January 2018

1 reference

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

21 January 2018

1 reference

Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans

21 January 2018

1 reference

Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice

21 January 2018

1 reference

Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.

21 January 2018

1 reference

Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.

21 January 2018

1 reference

Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: implication of different mechanism from pioglitazone.

21 January 2018

1 reference

Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes

21 January 2018

1 reference

Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes

21 January 2018

1 reference

Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people

21 January 2018

1 reference

Serum adiponectin concentrations are not related to glycosylated hemoglobin levels (HbA1c) in obese diabetic and non-diabetic caucasians

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1055/S-2007-992116

Identifiers

DOI

10.1111/ECI.12207

1 reference

3 April 2018

PubMed ID

24251799

1 reference

3 April 2018